Further Funding for Sunderland Prodrug Development

We are pleased to announce that we have extended the funding to University of Sunderland to continue their work on Developing a Prodrug for the treatment of Cystinosis. This £75,000.00 of funding will support the pre-clinical work that is necessary to progress to pre-clinical trials and to further develop an ocular prodrug treatment. The project will run from February next year for around 14 months.

The work to date on developing suitable compounds for a Prodrug have progressed as expected with a strong candidate having been identified. Sunderland University continue to work on this with wider partners in the Cystinosis research community.

Comments are closed.

New Cystinosis Study – CTNS Nonsense Mutation Screen The McGill University in Canada is looking for participants in Europe and North America for a [...] Read more...
Cystinosis Education Day, 19th September 2017 A ‘Cystinosis Patient and Clinician Education Day’ is being held on Tuesday 19th [...] Read more...
Derby Moor Student an Inspiration to Us All Derby Moor student Eeshar Seehra was thrilled to achieve 3 A Levels in Maths, Physics and [...] Read more...
Newsletter – November 2012 Issue 21 of the Foundation newsletter has recently been finalised and is available to download [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday